rs188006077
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PS3PP3_ModeratePP5_Very_Strong
The NM_001406875.1(PMS2):c.-166C>T variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.00000813 in 1,598,850 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000187425: "In an in vitro mismatch repair (MMR) complementation assay, the MMR activity of p.R107W was reduced to less than 20% compared to wild type (100%), which was similar to other pathogenic/likely pathogenic variants in the assay (van der Klift HM et al. Hum. Mutat. 2016 11" and additional evidence is available in ClinVar. The gene PMS2 is included in the ClinGen Criteria Specification Registry.
Frequency
Consequence
NM_001406875.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Lynch syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- mismatch repair cancer syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001406875.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | MANE Select | c.319C>T | p.Arg107Trp | missense | Exon 4 of 15 | NP_000526.2 | P54278-1 | ||
| PMS2 | c.-166C>T | 5_prime_UTR_premature_start_codon_gain | Exon 4 of 15 | NP_001393804.1 | |||||
| PMS2 | c.-166C>T | 5_prime_UTR_premature_start_codon_gain | Exon 4 of 15 | NP_001308944.1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | TSL:1 MANE Select | c.319C>T | p.Arg107Trp | missense | Exon 4 of 15 | ENSP00000265849.7 | P54278-1 | ||
| PMS2 | TSL:1 | c.319C>T | p.Arg107Trp | missense | Exon 4 of 11 | ENSP00000371758.4 | P54278-2 | ||
| PMS2 | TSL:1 | n.319C>T | non_coding_transcript_exon | Exon 4 of 13 | ENSP00000514464.1 | P54278-3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152078Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000127 AC: 3AN: 236786 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000829 AC: 12AN: 1446654Hom.: 0 Cov.: 29 AF XY: 0.00000416 AC XY: 3AN XY: 720294 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74408 show subpopulations
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at